Representation of Health System: DEA Investigation and Diversion Response

We represent a health system in connection with a DEA investigation arising from a significant diversion event at one of its hospitals. We have assisted the client with the investigation of the diversion, responses to state and federal agencies, preparation for regulatory inspections, and production of documents to the DEA and other regulators. We also advise the health system on systemwide controlled substances compliance enhancements and diversion prevention measures. Discussions with a U.S. Attorney’s Office regarding the matter remain ongoing.